Question 1

Does Los Angeles Capital Management own ARQT stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Los Angeles Capital Management holds 137,929 shares of ARQT (Arcutis Biotherapeutics), worth $3.6M.

Question 2

How many shares of ARQT does Los Angeles Capital Management own?

Accepted Answer

As of its Q2 2026 13F, Los Angeles Capital Management holds 137,929 shares of ARQT (Arcutis Biotherapeutics).

Question 3

What is Los Angeles Capital Management's ARQT position worth?

Accepted Answer

As of its Q2 2026 13F, Los Angeles Capital Management's ARQT position is worth $3.6M.

Question 4

Is Los Angeles Capital Management buying or selling ARQT?

Accepted Answer

In Q2 2026, Los Angeles Capital Management reduced its ARQT position by 16,493 shares (-10.7%).

Question 5

When did Los Angeles Capital Management first buy ARQT?

Accepted Answer

Los Angeles Capital Management first reported ARQT in its Q2 2021 13F and has listed it in 15 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	137,929	-10.7%	$3.6M	0.0%	$26.22	0
2026-Q1	Increased	154,422	+139.4%	$3.6M	0.0%	$23.56	43
2025-Q4	Increased	64,503	+2.4%	$1.6M	0.0%	$29.04	26
2025-Q3	Increased	63,025	+104.2%	$1.2M	0.0%	$18.85	41
2025-Q2	Unchanged	30,863	0.0%	$432,699	0.0%	$14.02	0
2025-Q1	Increased	30,863	+0.2%	$482,697	0.0%	$15.64	24
2024-Q4	Decreased	30,793	-75.4%	$428,946	0.0%	$13.93	0
2024-Q3	Decreased	125,103	-8.0%	$1.2M	0.0%	$9.30	0